89

Ozone treatment refers to physiotherapeutic methods and, first of all, should contribute to the effectiveness of the main course of treatment.
Ionized oxygen has a profound stabilizing effect on the metabolic processes in the tissues of the heart and blood vessels. With the help of ozone
therapy sessions, it is possible to significantly improve the quality of life for a sick person. The problem of treating patients with coronary heart
disease (CHD) is urgent due to the increasing frequency of the disease. CHD is a disease of the heart muscle caused by a violation of the balance
between coronary blood flow and the metabolic needs of the heart muscle. In recent years, medical ozone has been used to normalize the oxygen
supply of tissues. By changing the structure of membrane lipids, ozone increases the deformability of erythrocytes and thereby improves the
rheological properties of blood. It has a vasodilating effect, significantly improves the oxygen output by oxyhemoglobin

  • O'qishlar soni 89
  • Nashr sanasi 15-12-2022
  • Asosiy tilIngliz
  • Sahifalar87-90
English

Ozone treatment refers to physiotherapeutic methods and, first of all, should contribute to the effectiveness of the main course of treatment.
Ionized oxygen has a profound stabilizing effect on the metabolic processes in the tissues of the heart and blood vessels. With the help of ozone
therapy sessions, it is possible to significantly improve the quality of life for a sick person. The problem of treating patients with coronary heart
disease (CHD) is urgent due to the increasing frequency of the disease. CHD is a disease of the heart muscle caused by a violation of the balance
between coronary blood flow and the metabolic needs of the heart muscle. In recent years, medical ozone has been used to normalize the oxygen
supply of tissues. By changing the structure of membrane lipids, ozone increases the deformability of erythrocytes and thereby improves the
rheological properties of blood. It has a vasodilating effect, significantly improves the oxygen output by oxyhemoglobin

№ Muallifning F.I.Sh. Lavozimi Tashkilot nomi
1 Khusainova .A. ассистент Samarqand davlat tibbiyot universiteti
№ Havola nomi
1 1. Agababyan, I., Soliyeva, S., & Ismoilova, Y. (2021). Condition Of Coronary Arteries And Change Of Lipid Profile In Coronary Heart Disease. Annals Of The Romanian Society For Cell Biology, 207-213. 2. Alisherovna, K. M., & Tatlibayevich, Y. S. (2021). Assessment Of Risk Factors For Arterial Hypertension Hypertension In Pregnant Women. Central Asian Journal Of Medical And Natural Sciences, 2(3), 214-217. 3. Alisherovna, K. M., Alisherovich, B. Z., Ilyosxonovich, K. I., & Oybekovna, E. E. (2022). Changes In Hemodynamics Of The Cardiovascular System In Patients With Fibrosis Alveolitis. Spectrum Journal Of Innovation, Reforms And Development, 4, 203-209. 4. Buribayevich, N. M. (2022). Applications The Drug Nicomex At Treatment Of Patients With Chronic Heart Failure And Type 2 Diabetes Mellitus. Web Of Scientist: International Scientific Research Journal, 3(5), 597-605. 5. Buribayevich, N. M. (2022). Treatment Of Chronic Heart Failure In Patients With Type 2 Diabetes Mellitus. Central Asian Journal Of Medical And Natural Sciences, 3(1), 183-186. 6. Djamshedovna, K. D. (2021). Echocardiographic Signs F Chf In Patients With Essential Hypertension. Web Of Scientist: International Scientific Research Journal, 2(11), 192-196. 7. Gafforov, X. (2021). Jigar Sirrosi Kasalligida Yurakning Sistolik Va Diastolik Disfunktsiyasining Ahamiyati. Журнал Кардиореспираторных Исследований, 2(1), 67-69. 8. Khabibovna, Y. S., & Abdukodirovna, A. S. (2021). Changes In The Diastolic Function Of The Right Ventricle In Arterial Hypertension. Web Of Scientist: International Scientific Research Journal, 2(11), 161-169. 9. Shodikulova, G. Z., Pulatov, U. S., Ergashova, M. M., Tairova, Z. K., & Atoev, T. T. (2021). The Correlation Among Osteoporosis, Calcium-Phosphore Metabolism And Clinical Symptoms Of Main Disease In Patients With Rheumatoid Arthritis. Annals Of The Romanian Society For Cell Biology, 4185-4190. 10. Toshtemirovna, E. M. M., Alisherovna, K. M., Totlibayevich, Y. S., & Muxtorovna, E. M. (2022). Hearts In Rheumatoid Arthritis: The Relationship With Immunological Disorders. Spectrum Journal Of Innovation, Reforms And Development, 4, 34-41. 11. Xudoyberdiyevich, G. X. (2022). Heart Failure, Diabetes Mellitus, Beta Blockers And The Risk Of Hypoglycemia. Spectrum Journal Of Innovation, Reforms And Development, 4, 42-48. 12. Yarmatov, S. T. (2021). Yurak Ishemik Kasalligi Va Bachadon Miomasi Bo'lgan Bemorlarni Davolashda Antikougulyant Va Antitrombositar Terapiyani O’tkazish Bo’yicha Klinik Kuzatuvni Olib Borish. Scientific Progress, 2(3), 792-797. 13. Yarmatov, S. T., & Xusainova, M. A. (2021). Yurak Ishemik Kasalligi Mavjud Bo’lgan Bemorlarda. Scientific Progress, 2(3), 785-791. 14. Yarmatov, S. T., & Yarmahammadov, U. K. (2022). Semizlik–Zamonaviy Tibbiyotda Dolzarb Muammo Sifatida Qolmoqda. Scientific Progress, 3(4), 1196-1203. 15. Zikriyaevna, S. G., & Muhtorovna, E. M. (2019). The Features Of The Early Diagnostics Of Osteoporosis In Patients With Rheumatoid Arthritis. Достижения Науки И Образования, (12 (53)), 110-112. 16. Камолова, Д. Ж. (2022). Structural-Geometrical Changes Of The Myocardium And The Particularities Of The Left Ventricle Of The Heart In A Pregnant Women With A Different Types Of Arterial Hypertension. Журнал Кардиореспираторных Исследований, 3(1). 17. Норматов, М. Б. (2022). Efficacy Of Amlodipine In Arterial Hypertension Combined With Type 2 Diabetes Mellitus. Журнал Кардиореспираторных Исследований, 3(1). 18. Ярмухаммедова, С. (2020). Оценка Признаков Диастолической Дисфункции Правого Желудочка У Больных С Артериальной Гипертонией. Журнал Кардиореспираторных Исследований, 1(2), 88-92. 19. Элламонов С. Н. и др. Факторы прогрессирования артериальной гипертензии у больных в коморбидности с сахарным диабетом 2 типа //Журнал кардиореспираторных исследований. – 2021. – Т. 2. – №. 2. 20. Ташкенбаева Э. Н. и др. АССОЦИИРОВАННЫЕ ФАКТОРЫ РИСКА КАРДИОВАСКУЛЯРНЫХ СОБЫТИЙ У ЖЕНЩИН В ПОСТМЕНОПАУЗАЛЬНОМ ПЕРИОДЕ //Журнал кардиореспираторных исследований. – 2020. – Т. 1. – №. 3. 21. Мирзаев Р. З., Ташкенбаева Э. Н., Абдиева Г. А. ПРОГНОСТИЧЕСКИЕ КЛИНИЧЕСКИЕ МАРКЕРЫ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ ПРИ МЕТАБОЛИЧЕСКОМ СИНДРОМЕ //Журнал кардиореспираторных исследований. – 2022. – №. SI- 2. 22. Ташкенбаева Э. Н. и др. Механизмы кардиозащитных эффектов десфлурана и севофлурана во время реперфузии //Журнал кардиореспираторных исследований. – 2021. – Т. 2. – №. 2.
Kutilmoqda